Online citations, reference lists, and bibliographies.

Is E-cadherin Immunoexpression A Prognostic Factor For Head And Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review And Meta-analysis.

Zhigang Zhao, Jie Ge, Yanan Sun, Linli Tian, Jianguang Lu, Ming Liu, Yashuang Zhao
Published 2012 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
We summarized existing evidence about whether the aberrant E-cadherin expression is a prognostic factor for patients with HNSCC. Identifying relevant articles, filtrating studies and extracting data were independently conducted by two reviewers. The quality of eligible studies was assessed according to systematic score criteria. Associations between aberrant E-cadherin expression and overall survival (OS) or disease-free survival (DFS) were summarized by hazard ratio (HR) estimates. Random or fixed effects models were used to investigate the effect of E-cadherin across the studies. According to the multivariate and univariate analyses, the meta-analysis of the included studies gave a statistically significant pooled HR for OS in HNSCC [the pooled HR=2.533; 95% confidence interval (CI)=1.971-3.254]. In addition, the subgroup analyses showed that the pooled HR of each subgroup also exhibited statistical significance according to the subpopulations (Asian and other subpopulations), treatments (surgery and other treatments), locations of primary tumors (oral cavity and other subsites), and data sources of HR (reported and estimated HR). Similar to the results of OS, the analysis of four included trials showed that the aberrant E-cadherin expression could predict low DFS. Meanwhile, a cumulative meta-analysis showed that the pooled HR became statistically significant. However, a meta-regression analysis showed that the OS was not statistically significant with the cutoff values of the included studies. Our study gives an important piece of evidence that aberrant E-cadherin expression was associated with a poor prognosis in patients with HNSCC.
This paper references
10.1083/jcb.108.6.2435
Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
J. Behrens (1989)
10.1016/S0959-8049(97)00237-2
The current contribution of molecular factors to risk estimation in neuroblastoma patients.
Frank Berthold (1997)
10.1097/CEJ.0b013e32832f9aa6
Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma
Jian Zou (2010)
10.1186/1745-6215-8-16
Practical methods for incorporating summary time-to-event data into meta-analysis
J. Tierney (2007)
10.1017/S0022215100106553
Interest in frozen section examination of margins and lymph nodes in laryngeal surgery.
Marc Remacle (1988)
10.1136/jcp.2004.024786
Prognostic value of activated Akt expression in oral squamous cell carcinoma
J. Lim (2005)
Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
H. Muramatsu (2008)
10.1016/j.oraloncology.2006.07.003
Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence.
Amanajás Francisco Carlos de Aguiar (2007)
10.1002/CNCR.2820690526
Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases.
Laura Ciuró Cerezo (1992)
10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.
M. K. Parmar (1998)
10.1159/000027746
Diagnostic Procedures for Detection of Lymph Node Metastases in Cancer of the Larynx
Rosemarie Kau (2000)
10.1034/j.1600-0714.2002.00147.x
Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.
Á. Bánkfalvi (2002)
10.1002/cncr.23889
African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients.
M. A. Molina (2008)
10.1002/ijc.20782
E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components.
F. X. Bosch (2005)
10.2188/jea.15.235
Systematic evaluation and comparison of statistical tests for publication bias.
Y. Hayashino (2005)
10.1111/j.1600-0714.2006.00474.x
Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma.
K. Hung (2006)
E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.
J. Schipper (1991)
10.1007/s10555-005-5051-5
Progression of head and neck squamous cell cancer
J. Tímár (2005)
10.1158/1940-6207.CAPR-09-0149
Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients
Kathleen Settle (2009)
10.1111/j.1349-7006.2009.01357.x
Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer.
M. Vered (2010)
10.1002/cncr.23557
Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
S. Muller (2008)
10.1016/j.oraloncology.2009.07.007
Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients.
Gordana Supic (2009)
10.7326/0003-4819-144-6-200603210-00010
Evaluation of the Quality of Prognosis Studies in Systematic Reviews
J. Hayden (2006)
10.1038/modpathol.2009.160
Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome
Lai-kui Liu (2010)
10.1016/j.oraloncology.2005.07.010
Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
M. Diniz-Freitas (2006)
10.1007/s10549-006-9248-2
E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis
Bonnie E. Gould Rothberg (2006)
10.1016/j.otohns.2005.08.026
Decreased E-Cadherin but not β-Catenin Expression is Associated with Vascular Invasion and Decreased Survival in Head and Neck Squamous Carcinomas
K. Kurtz (2006)
10.1016/j.anl.2011.04.003
Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma.
Jing-jia Li (2012)
10.1007/s11060-010-0204-y
P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature
Georgia Levidou (2010)
10.1016/j.ijom.2005.07.023
Aberrant expression of β- and γ-catenin is an independent prognostic marker in oral squamous cell carcinoma
Gosei Ueda (2006)
10.1136/bmj.323.7306.224
Systematic reviews of evaluations of prognostic variables
D. Altman (2001)
10.1126/science.2006419
Cadherin cell adhesion receptors as a morphogenetic regulator.
M. Takeichi (1991)
10.1007/s004320000177
A comparative study of the clinicopathological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinoma
Vivian Chow (2001)
10.1097/JTO.0b013e3181a97e31
Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis
Ping Zhan (2009)
10.1002/ijc.2910550411
E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome.
V. Mattijssen (1993)
10.1038/sj.bjc.6602678
REporting recommendations for tumour MARKer prognostic studies (REMARK)
Lisa M. McShane (2005)
10.1158/1078-0432.CCR-10-3284
Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis
N B Jamieson (2011)
10.1146/annurev.bi.59.070190.001321
Cadherins: a molecular family important in selective cell-cell adhesion.
M. Takeichi (1990)
10.1093/jnci/dji237
Reporting recommendations for tumor marker prognostic studies (REMARK).
L. McShane (2005)
10.1016/j.tripleo.2008.11.021
The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.
X. Wang (2009)
10.1097/00129039-200412000-00006
Prognostic Significance of Dysadherin Expression in Tongue Cancer: Immunohistochemical Analysis of 91 Cases
Yukihiro Nakanishi (2004)
10.1038/sj.bjc.6601095
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
B. Martin (2003)
10.1016/j.jcms.2006.11.004
Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
S. W. Pyo (2007)
10.3322/caac.20107
Global cancer statistics.
A. Jemal (2011)
Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors.
Shmuel Eidelman (1989)
10.1002/hed.21584
Determinants of head and neck cancer survival by race.
Camille C Ragin (2011)
10.1080/00313020802320614
Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients
M. Wong (2008)
10.1016/S0959-8049(01)00399-9
Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features.
J. Rodrigo (2002)
10.1016/j.archoralbio.2007.01.013
Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
L. Zhong (2007)



This paper is referenced by
10.9734/JAMMR/2019/V29I930127
E-Cadherin as a Marker for Nodal Metastasis in Head and Neck Squamous Cell Carcinoma
Saima Akram Butt (2019)
10.14670/HH-11-616
E-cadherin, β-catenin, and α2β1 and α3β1 integrin expression in primary oral squamous cell carcinoma and its regional metastasis.
Mariana Quirino Silveira Soares (2015)
Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.
T. Li (2014)
10.1016/j.canlet.2013.09.033
Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition.
Chang-yun Yu (2014)
10.1007/s12105-012-0391-2
Acantholytic Squamous Cell Carcinoma in Upper Aerodigestive Tract: Histopathology, Immunohistochemical Profile and Epithelial Mesenchymal Transition Phenotype Change
Xin Gu (2012)
10.4103/ijd.IJD_520_17
Re-appraisal of Keratinocytes' Role in Vitiligo Pathogenesis
Ola Ahmed Bakry (2018)
10.37358/rc.18.10.6596
HPV18 Associated with E-cadherin Expression in Head and Neck Squamous Cell Carcinoma
Simina Boia (2018)
10.1002/lary.25736
The prognostic role of E-cadherin and β-catenin overexpression in laryngeal squamous cell carcinoma.
Antonio Greco (2016)
10.1007/s00432-013-1499-9
Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma
Chi-Chen Fan (2013)
10.1111/cyt.12468
Epithelial oral mucosal cells: Do they behave differently when exposed to oral carcinogens?
A D da Silva (2018)
10.2147/OTT.S98577
E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations
Xusheng Ren (2016)
10.3389/fonc.2019.00021
Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness, and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer
S. Kampo (2019)
10.1016/j.oooo.2018.11.003
Twist and E-cadherin deregulation might predict poor prognosis in lower lip squamous cell carcinoma.
Everton Freitas de Morais (2019)
Prognostic markers in oral squamous cell carcinoma
Oddveig G. Rikardsen (2014)
Immunohistochemical evaluation of epithelial Mesenchymal transition proteins in oral Pre malignant and malignant lesions
Punnya V. Angadi (2012)
10.1016/j.biomaterials.2017.08.011
Application of three-dimensional collagen scaffolds to recapitulate and monitor the dynamics of epithelial-mesenchymal transition during tumor satellite formation of head and neck cancer.
Chun-Nan Chen (2018)
10.1016/j.archoralbio.2015.10.003
Expression of adhesion proteins (E-cadherin and β-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas.
Carlos Henrique Pereira (2016)
10.4317/medoral.23305
Prognostic value of the immunohistochemical detection of epithelial-mesenchymal transition biomarkers in oral epithelial dysplasia: A systematic review
Everton Freitas de Morais (2020)
10.1007/s40291-018-0351-y
The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis
Javad Yazdani (2018)
10.1002/9780470015902.A0025738
SWI/SNF Chromatin Remodelling and Human Cancer
David N. Reisman (2016)
10.1016/j.canlet.2014.08.035
N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Jehn-Chuan Lee (2014)
10.3892/ijo.2015.3226
IL-8 suppresses E-cadherin expression in nasopharyngeal carcinoma cells by enhancing E-cadherin promoter DNA methylation.
R. Zhang (2016)
10.3892/ol.2018.8509
Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Chao Ma (2018)
10.1111/eci.12343
Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysis.
Ping Zhang (2014)
10.18632/oncotarget.14860
Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis
Zhan Li (2017)
10.18632/oncotarget.10593
Mechanism of BRG1 silencing in primary cancers
Stefanie B. Marquez (2016)
10.5772/60081
Radioresistance in Head and Neck Squamous Cell Carcinoma — Possible Molecular Markers for Local Recurrence and New Putative Therapeutic Strategies
Federica Ganci (2015)
The role of galanin in perineural invasion of head and neck cancer
Christina Springstead Scanlon (2014)
SQUAMOUS CELL CARCINOMA OF THE ORAL TONGUE: STUDIES OF BIOMARKERS CONNECTED TO HUMAN PAPILLOMAVIRUS INFECTION, EPITHELIAL TO MESENCHYMAL TRANSITION AND LOCOREGIONAL METASTASIS
Nicola Sgaramella (2017)
10.1111/eci.12608
The prognostic implication of slug in all tumour patients - a systematic meta-analysis.
Cheng Huang (2016)
10.1007/978-3-319-23297-3_4
Biomarkers for Individualized Oral Cancer Therapy
Nisha J. D’silva (2015)
10.1002/hed.24897
Prognostic significance of E‐cadherin and &bgr;‐catenin expression in HPV‐negative oropharyngeal squamous cell carcinomas
Juana María García-Pedrero (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar